Ann Arbor, MI, United States of America

Usha Josyula

This inventor holds 2 USPTO granted patents. Top assignee: Warner-Lambert Company. Active years: 1993-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Usha Josyula. Retrieved from https://idiyas.com/inventor/usha-josyula

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1993-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Usha Josyula: Innovator in Pharmaceutical Chemistry

Introduction

Usha Josyula is a prominent inventor based in Ann Arbor, MI (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 2 patents, her work focuses on innovative solutions for treating various autoimmune diseases.

Latest Patents

Usha Josyula's latest patents include the invention of 9-Substituted-8-halo or -8-hydroxy-9-deazaguanines as inhibitors of purine nucleoside phosphorylase (PNP). These compounds are designed to be selectively cytotoxic to T-cells while sparing B-cells in the presence of 2'-deoxyguanosine. This unique property makes them valuable for treating conditions such as autoimmune diseases, gout, psoriasis, and transplant rejection. The patents also encompass certain novel intermediates that contribute to the efficacy of these compounds.

Career Highlights

Usha Josyula is currently associated with Warner-Lambert Company, where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on therapeutic strategies in immunology and oncology.

Collaborations

Usha collaborates with Jagadish C Sircar, enhancing her research through shared expertise and innovative ideas.

Conclusion

Usha Josyula's contributions to pharmaceutical chemistry exemplify the importance of innovation in developing new treatments for complex diseases. Her patents reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…